Current position:Home >Product >
4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-[2-(2,3-dihydroindol-1-yl)-2-oxidanylidene-ethyl]thiophene-2-sulfonamide
4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-[2-(2,3-dihydroindol-1-yl)-2-oxidanylidene-ethyl]thiophene-2-sulfonamide
|
|
Canonical SMILES:
C1CC(C1)C2=NC(=NO2)C3=CSC(=C3)S(=O)(=O)NCC(=O)N4CCC5=CC=CC=C54
Isomeric SMILES
C1CC(C1)C2=NC(=NO2)C3=CSC(=C3)S(=O)(=O)NCC(=O)N4CCC5=CC=CC=C54
InChI
InChI=1S/C20H20N4O4S2/c25-17(24-9-8-13-4-1-2-7-16(13)24)11-21-30(26,27)18-10-15(12-29-18)19-22-20(28-23-19)14-5-3-6-14/h1-2,4,7,10,12,14,21H,3,5-6,8-9,11H2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 4-(5-cyclobutyl-1,2,4-oxadiazol-3-yl)-N-[2-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-oxidanylidene-ethyl]thiophene-2-sulfonamide
- N-[2,5-bis(fluoranyl)phenyl]-3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-2H-indole-5-sulfonamide
- N-(4-ethanoylphenyl)-3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-2H-indole-5-sulfonamide
- N-(3,4-dimethoxyphenyl)-3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-2H-indole-5-sulfonamide
- N-(2,4-dimethoxyphenyl)-3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-2H-indole-5-sulfonamide
- 3,3-dimethyl-N-(4-methyl-1,3-thiazol-2-yl)-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-2H-indole-5-sulfonamide
- 3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-N-[2-(trifluoromethyl)phenyl]-2H-indole-5-sulfonamide
- 3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-N-[3-(trifluoromethyl)phenyl]-2H-indole-5-sulfonamide
- 3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-N-(pyridin-2-ylmethyl)-2H-indole-5-sulfonamide
- 3,3-dimethyl-1-(2-oxidanylidene-2-pyrrolidin-1-yl-ethyl)-N-(pyridin-3-ylmethyl)-2H-indole-5-sulfonamide

